CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale Chief Financial Officer sold 864 shares at $21.56 ($18,628)
- 4 Open-market sale President, R&D sold 1,429 shares at $21.56 ($30,809)
- 4 Open-market sale Chief Legal Officer sold 864 shares at $21.56 ($18,628)
- 4 Grant or award Rahmer Peter acquired 97,630 shares (grant or award)
- 4 Open-market sale President and CEO sold 84,000 shares at an average $20.37 ($1,711,360)
- 4 Grant or award Chief Financial Officer acquired 101,115 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 85,425 shares (grant or award)
- 4 Grant or award President, R&D acquired 160,390 shares (grant or award)
- 4 Open-market sale Chief Legal Officer sold 9,994 shares at $20.00 ($199,880)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 445 shares at $14.49 ($6,448)
- 4 Open-market sale President, R&D sold 980 shares at $14.49 ($14,200)
- 4 Open-market sale Chief Legal Officer sold 295 shares at $14.49 ($4,275)
- 4 Open-market sale President and CEO sold 42,000 shares at an average $20.06 ($842,520)
- 4 Open-market sale Chief Administrative Officer sold 448 shares at $21.54 ($9,650)
- 4 Open-market sale Chief Financial Officer sold 1,099 shares at $21.54 ($23,672)
- 4 Open-market sale President, R&D sold 9,817 shares at an average $22.53 ($221,138)
- 4 Open-market sale Chief Legal Officer sold 728 shares at $21.54 ($15,681)
- 4 Open-market sale President and CEO sold 42,000 shares at an average $21.04 ($883,680)
- 4 Open-market sale President, R&D sold 8,000 shares at $22.43 ($179,440)
Page 10 of 16 · 320 filings